Why did PA8.F stock spike intraday on 02 Feb 2026?

The spike was driven by extremely thin liquidity and concentrated buy orders; volume jumped to **4,600** from an average **850**, indicating speculative flow rather than confirmed corporate news.

What is Meyka AI's rating for PA8.F?

Meyka AI rates PA8.F **58.75 / 100 (C+) — Suggestion: HOLD**. The grade combines benchmark, sector, financial growth, key metrics and analyst signals and is for information only.

What are the near‑term price forecasts for PA8.F stock?

Meyka AI's forecast model projects **EUR 0.020** in one month (model‑based), which implies **-97.64%** from the current **EUR 0.848**. Forecasts are projections and not guarantees.

How should traders manage PA8.F trading risk?

Use limit orders, small position sizes, and a strict stop strategy. The stock is micro‑cap with high volatility and low liquidity, increasing execution and price‑impact risk.

DE Stocks

PA8.F Paion AG (XETRA) rises 1,313.33% intraday on 02 Feb 2026: monitor liquidity

ByDanny Kontos February 2, 2026February 2, 2026

PA8.F stock jumped 1,313.33% intraday to EUR 0.848 on XETRA on 02 Feb 2026, driven by a thin order book and heavy relative volume. The move followed an open at EUR 0.848 versus a previous close of EUR 0.06, producing a surge in trading activity with 4,600 shares changing hands so far. Traders should note the stock’s low free float and the healthcare sector’s muted 1‑day move of +1.05%, which shows this spike is idiosyncratic rather than sector‑wide.